STAT+: House Democrats slip drug-pricing proposal into Covid-19 relief bill

WASHINGTON — House Democrats are expected to insert a controversial Medicaid drug pricing policy into a fast-moving Covid-19 relief bill, several health care lobbyists and a congressional aide briefed on the package told STAT.

The policy aims to help states recoup some of the costs they incur in their Medicaid programs when drug makers hike the prices of certain drugs. Right now, federal law caps how much states can collect. Congress’s new policy would rescind that so-called “Medicaid rebate cap.”

Continue to STAT+ to read the full story…

Read Original Article: STAT+: House Democrats slip drug-pricing proposal into Covid-19 relief bill »